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 博士論文題目 Overexpression of stomatin-like protein 2 drives epithelial mesenchymal transition 
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【Background】Pancreatic cancer (PC) is one of the most dismal types of cancer. Researchers at my 
institute identified stomatin-like protein 2 (SLP-2) as a new PC prognostic marker by mass-spectrometry 
based proteomics analysis using formalin-fixed paraffin-embedded tissues. SLP-2 is located mainly in 
mitochondria and regulates their stability. SLP-2 expression correlates with the malignant prognosis of 
different cancers. However, detailed analyses and the pathogenetic mechanisms explaining their 
correlation remain unclear for PC.  
【Aim】To elucidate the SLP-2 pathogenic mechanisms and their correlation with prognosis in patients 
with PC. 
【Method】Microarrays were used to detect altered gene expression profiles in tumor cells, as well as in 
vitro analyses such as migration and invasion assays. A splenic injection model was used to confirm the 
SLP-2 function in SCID mice. Finally, the clinicopathological characteristics (including SLP-2 
immunohistochemical staining) and prognoses of 202 patients with PC were retrospectively reviewed. 
【Result】Microarray analyses revealed several epithelial mesenchymal transition(EMT)-related genes 
with altered expression in PC cells with both high and low SLP-2 expression. In SLP-2 silenced cells, the 
expression of e-cadherin was elevated, and those of vimentin and ZEB1 were decreased. Migration and 
invasion activities were also decreased in cells with reduced SLP-2 expression. SLP-2 was expressed 
mainly in the mitochondrial fraction and its silencing decreased the glucose uptake of cancerous cells. In 
vivo analyses demonstrated that the number of liver metastases was significantly reduced in cells with 
low SLP-2 expression. Patients with high SLP-2 expression showed worse disease-specific survival (DSS) 
(P < 0.001) and recurrence-free survival (RFS) (P < 0.001) than those with low SLP-2 expression. 
Moreover, my analyses indicated that SLP-2 expression may serve as a predictive factor of DSS (hazard 
ratio [HR] 2.18; P < 0.001) and RFS ([HR] 1.63; P = 0.027).  
【Conclusion】SLP-2 expression may be useful as a predictive factor of recurrence and survival after 
curative resection in PC. SLP-2 exerts its malignant function by driving the metastatic potential via its 
EMT pathway regulation. 
